Wendexilin (Hangzhou) Biotechnology Co., Ltd., established on 2019-12-17, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Cosmetics Retail;Cosmetics Wholesale;Sales of Class II Medical Devices;Sales of Class I Medical Devices;Production of Class I Medical Devices;Manufacturing of bio-based materials;Sales of bio-based materials;property management(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Cosmetic production;Production of Class II Medical Devices;Class III medical device business;Production of Class III Medical Devices(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).

Tissuemed LTD is a UK-based medical technology company that develops tissue-based therapeutic devices like the first tissue heart valve to gain regulatory approval in Europe. The company also specializes in bioadhesives, adhesive films to prevent air, blood and fluid leaks encountered in surgery. The company has a reputation for innovation dating back over twenty years. Following divestiture of the heart valve business in 1999, Tissuemed focused its considerable scientific expertise on the development of surgical sealants. Five years of research and development yielded the TissuePatch™ product family, which is now at the core of the company’s activities. These unique surgical films have been designed specifically to help surgeons to effectively seal tissues against leakage air, blood and other fluids, including Cerebrospinal Fluid (CSF).

National Institute for Materials Science (物質・材料研究機構 Busshitsu-zairyō kenkyū kikō) is an Independent Administrative Institution and one of the largest scientific research centers in Japan.

Polyganics BV engages in the development, manufacture, and commercialization of bioresorbable medical devices that facilitate tissue repair and regeneration. It offers pipeline, peripheral nerve repair, neurosurgery, and general surgery products . The company was founded in 1999 and is headquartered in Groningen, the Netherlands.

Nycomed is a privately owned global pharmaceutical company with a diversified portfolio focused on branded medicines in gastroenterology, respiratory and inflammatory diseases, pain, osteoporosis and tissue management. A range of OTC products completes the portfolio. Its R&D is structured around collaborations. In-licensing and expanding in emerging markets are cornerstones of the company's growth strategy. Nycomed employs 12,500 associates worldwide, and its products are sold in more than 100 countries. It has strong platforms in Europe and in fast-growing markets such as Russia/CIS, Latin America, Asia and the Middle East. In the US and Japan its products are available through best in class partners. Headquartered in Zurich, Switzerland, the company generated total sales of € 3.2 billion in 2010 and an adjusted EBITDA of € 851 million.

Focal Inc, is a developing biodegradable interventional therapeutic products to treat serious local diseases. The company products consist of a biodegradable polymer system that can deliver drugs locally to the site of disease and/or act as a physical barrier. Other Focal research & development programs include polymer and drug delivery products to: prevent adhesions (internal scar tissue) following surgery; serve as surgical sealants; and deliver drugs locally for other indications.

Ethicon, Inc. is a subsidiary of Johnson & Johnson. It was incorporated as a separate company under the Johnson & Johnson umbrella in 1949 to expand and diversify the Johnson & Johnson product line. Ethicon has manufactured surgical sutures and wound closure devices since 1887. After World War II, Ethicon's market share in surgical sutures rose from 15% to 70% worldwide. In the United States, the market share is approximately 80%.

Haining Jurassic Biotechnology Co., Ltd. is a company headquartered in China that engages in the research and development and transformation of biotechnology, biomaterials, stem cells and anti-aging technologies.

Sanofi Genzyme is the specialty care global business unit of Sanofi, focused on rare diseases, multiple sclerosis, immunology, and oncology. They help people with debilitating and complex conditions that are often difficult to diagnose and treat. They are dedicated to discovering and advancing new therapies, providing hope to patients and their families around the world. Genzyme became part of Sanofi in 2011. While continuing to focus on rare diseases, they also established ourselves as a leader in the field of multiple sclerosis. In 2016, their focus expanded to include Sanofi’s programs in oncology and immunology. Their approach is shaped by a long history of developing highly specialized treatments and forging close relationships with physician and patient communities. Founded as Genzyme in Boston in 1981, they rapidly grew to become one of the world’s leading biotechnology companies, recognized for their pioneering development of treatments for rare genetic disorders and their innovative contributions to medical science and biomanufacturing.

Adhesys Medical GmbH develops polyurethane-based tissue and organ glue. It develops biodegradable wound sealing technology which can be used as a tissue adhesive to re-connect tissue or organs after surgery and as a tissue sealant to seal external wounds and to seal air and fluid leakages of organs. The company was founded by Heike Heckroth, René Tolba, Malte Brettel and Marius Rosenberg in 2013 and is headquartered in Aachen, Germany.

Nurami Medical Ltd. develops surgical scaffold platform for the repair, regeneration and healing of soft tissues following internal surgeries. Its product pipeline include Artifascia and Artifix. The company was founded by Amir Bahar and Nora Nseir in 2014 and is headquartered in Haifa, Israel.

GATT Technologies BV develops a soluble surgical tape. It manufactures a polymer-based general adhesive tissue tape that is used as a surgical sealant for various surgical applications. The company was founded in August 2011 by Johan Bender and Andr�� de Lege and is headquartered in Nijmegen, the Netherlands.

Sichuan Blu-ray Inno Biotechnology Co., Ltd., established on 2014-09-16, Business scope includes research,to develop,production of biotechnology products;Biotechnology and Medical Technology Consulting,Technology Transfer and Technical Services;3Dprinting technology and3DPrint smart equipment,Research on Intelligent Printing Equipment and Auxiliary Equipment,to develop,Production and Technical Services;3D data processing and 3D digital technology consulting,Technology Transfer and Technical Services;Computer software development and technical services;Research,to develop,ProductionI,II,IIIClass medical devices and their accessories;Sales of our products and medical devices,Biological product,Electrical Equipment,Wujinjiaodian,Chemical Products(Does not contain dangerous goods);Import and export business of goods and technology.(The above business scope does not include items restricted or prohibited by national laws and regulations,Except those involving the implementation of special access management measures stipulated by the state,Those involving licenses can only carry out business activities with the relevant licenses).

Sealantium Medical is developing a bi-component hemostatic and sealing product composed of a polymeric film with a biological sealant. The control of hemorrhage is a critical step in first aid, trauma care and surgery, unfortunately, the materials and methods available to stop bleeding in pre-hospital care have not changed or improved greatly over the years. Sealantium Medical developed a biodegradable polymer Film that includes fibrin sealant. This new bio-surgical patch is developed as an effective device to control severs bleeding and seal leakages during and post-surgery.

Teijin Pharma Ltd. engages in the development, production, sales, and marketing of pharmaceuticals, and medical devices and supplies. The company operates in pharmaceutical and home healthcare businesses, focusing on bone and joint diseases, respiratory diseases, and cardiovascular and metabolic diseases. The company was founded in 2002 and is headquartered in Tokyo, Japan.

Nuoyimeier (Suzhou) Life Technology Co., Ltd., established on 2020-02-27, Business scope includes licensed projects:Cosmetic production;Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;Technology Import and Export;Import and export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Research and development of bio-based materials technology;Manufacturing of bio-based materials;Cosmetics Wholesale;Wholesale of Class II Medical Devices(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

BMG, Inc. develops medical products by using polymer chemistry technologies. The company was founded on June 28, 1983 by Suong-Hyu Hyon and is headquartered in Kyoto, Japan.

Ethicon LLC, part of Johnson & Johnson, is an American company located in Wilmington, DE, that manufactures surgical equipment.

Wonde Xilin (Shenyang) Biotechnology Co., Ltd., established on 2021-11-26, Business scope includes licensed projects:Cosmetic production,Production of Class II Medical Devices,Production of Class III Medical Devices,Class III medical device business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion,Cosmetics Wholesale,Cosmetics Retail,Production of Class I Medical Devices,Sales of Class I Medical Devices,Sales of Class II Medical Devices,Manufacturing of bio-based materials,Sales of bio-based materials,property management(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)